[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU5231186A - Amino-salicylic acid derivatives salts thereof process for their preparation and pharmaceutical compositions containing them - Google Patents

Amino-salicylic acid derivatives salts thereof process for their preparation and pharmaceutical compositions containing them

Info

Publication number
AU5231186A
AU5231186A AU52311/86A AU5231186A AU5231186A AU 5231186 A AU5231186 A AU 5231186A AU 52311/86 A AU52311/86 A AU 52311/86A AU 5231186 A AU5231186 A AU 5231186A AU 5231186 A AU5231186 A AU 5231186A
Authority
AU
Australia
Prior art keywords
amino
preparation
pharmaceutical compositions
compositions containing
acid derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU52311/86A
Inventor
Sportoletti Ciancarlo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Italfarmaco SpA
Original Assignee
Italfarmaco SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Italfarmaco SpA filed Critical Italfarmaco SpA
Publication of AU5231186A publication Critical patent/AU5231186A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/56—Amides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/12—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by acids having the group -X-C(=X)-X-, or halides thereof, in which each X means nitrogen, oxygen, sulfur, selenium or tellurium, e.g. carbonic acid, carbamic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU52311/86A 1984-11-29 1985-11-26 Amino-salicylic acid derivatives salts thereof process for their preparation and pharmaceutical compositions containing them Abandoned AU5231186A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT23799A/84 1984-11-29
IT23799/84A IT1196348B (en) 1984-11-29 1984-11-29 COMPOUNDS WITH ANTI-INFLAMMATORY ACTIVITY

Publications (1)

Publication Number Publication Date
AU5231186A true AU5231186A (en) 1986-06-18

Family

ID=11210091

Family Applications (1)

Application Number Title Priority Date Filing Date
AU52311/86A Abandoned AU5231186A (en) 1984-11-29 1985-11-26 Amino-salicylic acid derivatives salts thereof process for their preparation and pharmaceutical compositions containing them

Country Status (12)

Country Link
EP (1) EP0236329A1 (en)
JP (1) JPS62501703A (en)
KR (1) KR870700608A (en)
CN (1) CN85109554A (en)
AU (1) AU5231186A (en)
DK (1) DK346486A (en)
ES (1) ES8701717A1 (en)
GR (1) GR852834B (en)
IT (1) IT1196348B (en)
PT (1) PT81566B (en)
WO (1) WO1986003199A1 (en)
ZA (1) ZA859035B (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9017711D0 (en) * 1990-08-13 1990-09-26 May & Baker Ltd New compositions of matter
GB9017710D0 (en) * 1990-08-13 1990-09-26 May & Baker Ltd New compositions of matter
IT1244873B (en) * 1990-09-12 1994-09-12 Depha Team Srl DERIVATIVES OF 5-AMINOSALICYLIC ACID (5-ASA) FOR THE THERAPY OF CHRONIC INTESTINAL INFLAMMATIONS
US5366987A (en) * 1991-08-22 1994-11-22 Warner-Lambert Company Isoxazolyl-substituted alkyl amide ACAT inhibitors
FR2738150B1 (en) * 1995-09-01 1997-10-31 Synthelabo USE OF SULPHASALAZINE AND ITS METABOLITES FOR THE MANUFACTURE OF A MEDICAMENT USEFUL IN THE TREATMENT OF VENOUS INSUFFICIENCY AND VENOUS ULCERS
CA2405518C (en) * 2000-04-19 2009-07-07 Neurotech Co., Ltd. Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system
US6573402B1 (en) 2000-04-20 2003-06-03 Neurotech Co., Ltd. Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system
NO20013534L (en) * 2000-07-18 2002-01-21 Koyo Chemical Company Ltd Use of a composition comprising a glucosamine salt or a glucosamine derivative for the manufacture of a medicament for the treatment of human thrombosis
ATE462969T1 (en) 2001-01-19 2010-04-15 Apex Biotechnology Corp NON-ENZYMATIC DISPOSABLE DETECTION ELECTRODE STRIP CONTAINING A SURFACE-ACTIVE SUBSTANCE FOR DETECTING URIC ACID; PRODUCTION PROCESS AND USE THEREOF
EP1429765A2 (en) 2001-09-14 2004-06-23 Methylgene, Inc. Inhibitors of histone deacetylase
DK1551793T3 (en) 2002-06-19 2016-04-25 Gnt Pharma Co Ltd Tetrafluorobenzyl derivatives and pharmaceutical compositions containing these for the prevention and treatment of acute and chronic neurodegenerative diseases of the central nervous system
KR100668111B1 (en) 2005-07-28 2007-01-12 (주)에스에이치제약 New aminosalicylic acid analogs, it's pharmaceutically acceptable salts and their preparations
CN103211824B (en) 2006-04-13 2017-04-19 纽若泰克制药株式会社 Pharmaceutical composition for treating or preventing degenerative and inflammatory diseases
CN100422721C (en) * 2006-05-26 2008-10-01 南京大学 Aluminium ion investigating method using glycosyl naphthol
CN101842093B (en) * 2007-10-23 2012-08-22 株式会社医药分子设计研究所 PAI-1 production inhibitor
KR100852962B1 (en) 2007-11-12 2008-08-20 주식회사 뉴로테크 Manufacturing method of 2-hydroxy-5-phenylalkylaminobenzoic acid derivatives and their salts
US9085527B2 (en) 2008-07-08 2015-07-21 Catabasis Pharmaceuticals, Inc. Fatty acid acylated salicylates and their uses
ES2656793T3 (en) * 2008-07-08 2018-02-28 Catabasis Pharmaceuticals, Inc. Acetylated fatty acid salicylates and their uses
KR101204108B1 (en) * 2009-02-09 2012-11-22 주식회사 지엔티파마 Medicinal use of 5-benzylaminosalicylic acid derivative or its salt
USRE46608E1 (en) 2009-09-01 2017-11-14 Catabasis Pharmaceuticals, Inc. Fatty acid niacin conjugates and their uses
KR101685734B1 (en) 2009-09-01 2016-12-12 카타베이시스 파마슈티칼즈, 인코포레이티드 Fatty acid niacin conjugates and their uses
JP6202287B2 (en) * 2012-05-23 2017-09-27 セリックスビオ プライヴェート リミテッド Compositions and methods for the treatment of inflammatory bowel disease
US9822135B2 (en) 2012-10-30 2017-11-21 H. Lee Moffitt Cancer Center And Research Institute, Inc. STAT3 dimerization inhibitors
EP3902536A4 (en) * 2018-12-28 2022-09-28 GNT Pharma Co., Ltd Compositions and methods for treating neurodegenerative disorders
CN111116395B (en) * 2019-12-27 2023-04-07 湖北工业大学 Multi-iodo aromatic acid compound and application thereof in resisting adenovirus 7

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR4546M (en) * 1964-06-09 1966-11-02
NL7008623A (en) * 1969-06-25 1970-12-29
JPS5640710B2 (en) * 1973-01-18 1981-09-22
JPS6056130B2 (en) * 1978-03-20 1985-12-09 久光製薬株式会社 Novel salicylic acid derivatives
US4536346A (en) * 1983-05-06 1985-08-20 American Cyanamid Company Aralkanamidophenyl compounds

Also Published As

Publication number Publication date
PT81566B (en) 1987-04-07
GR852834B (en) 1986-03-27
CN85109554A (en) 1986-07-23
EP0236329A1 (en) 1987-09-16
DK346486D0 (en) 1986-07-21
IT8423799A0 (en) 1984-11-29
PT81566A (en) 1985-12-01
DK346486A (en) 1986-07-21
ES549359A0 (en) 1986-12-01
ES8701717A1 (en) 1986-12-01
JPS62501703A (en) 1987-07-09
ZA859035B (en) 1986-08-27
IT1196348B (en) 1988-11-16
WO1986003199A1 (en) 1986-06-05
KR870700608A (en) 1987-12-30

Similar Documents

Publication Publication Date Title
AU5231186A (en) Amino-salicylic acid derivatives salts thereof process for their preparation and pharmaceutical compositions containing them
PT86366A (en) Process for the preparation of phosphinic acid derivatives and of pharmaceutical compositions containing the same
IL76453A0 (en) Isoxazolecarboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
HUT43825A (en) Process for producing quinolon-carboxylic acid derivatives and pharmaceutical compositions containing them
HUT48902A (en) Process for producing new ribofuranuronic acid derivatives and pharmaceutical compositions containing them
IL74826A (en) 3-cephem-4-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
PH20703A (en) Quinolinecarboxylic acid derivatives process for their preparation and pharmaceutical composition containing them
HUT40639A (en) Process for producing quinolon-carboxylic acid derivative and pharmaceutical composition containing them
IL77849A0 (en) Aryldihydropyridinedicarboxylic acid ester derivatives,their preparation and pharmaceutical compositions containing them
AU537560B2 (en) Phenyl-alkanoic acid derivatives and their preparation and pharmaceutical compositions containing them
PT83565A (en) Process for the preparation of acid aryl-heterocyclic-alcoxi-acetic derivatives and of pharmaceutical compositions containing same
HUT41801A (en) Process for producing new cepheme-carboxylic acid derivatives and pharmaceutical compositions containing them
IL75603A0 (en) 1,3-dioxanylheptenoic acid derivatives,their preparation and pharmaceutical compositions containing them
HU895952D0 (en) Process for the preparation of substituted pyrrolidone-2-carboxylic acid derivatives and pharmaceutical compositions containing them
IL75913A0 (en) Phenyl-nonatetraenoic acid derivatives,their preparation and pharmaceutical compositions containing them
EP0168042A3 (en) Dihydroorotic acid derivatives, processes for their preparing and pharmaceutical composition containing them
ZA864504B (en) Derivatives of 2-fluoroalkylbenzimidazole,process for their preparation and pharmaceutical compositions containing them
IL80679A (en) 16,17-acetalsubstituted pregnane 21-oic acid derivatives,process for their preparation and pharmaceutical compositions containing them
PT80799B (en) Aminoeburnanecarboxylic acid derivatives pharmaceutical compositions containing them and process for preparing same
AU578104B2 (en) Pharmaceutical composition of peroxydiphosphoric acid derivatives
DE3661070D1 (en) 2-(substituted sulfamyl) derivatives of 6-nitrobenzoic acid, process for their preparation and pharmaceutical compositions containing them
PT80800A (en) Nitroapovincaminic acid derivatives pharmaceutical compositions containing them and process for preparing same
IL77799A0 (en) Dihydropyridinedicarboxylic acid ester derivatives,their preparation and pharmaceutical compositions containing them
IL89836A0 (en) Penicilanic acid derivatives,process for their preparation and pharmaceutical compositions containing them
IL69105A0 (en) Apovincaminic acid derivatives,process for their preparation and pharmaceutical compositions containing them